Patient and Physician Perspectives of Diabetic Retinopathy and Diabetic Macular Edema Diagnosis, Treatment and Progression: A Podcast Article by Daniel Newman, Bernadette Warren, Randall Barker, Charles C. Wykoff, Stela Vujosevic

Get full text

Imaging Features of Retinal Vasculitis and/or Retinal Vascular Occlusion after Brolucizumab Treatment in the Postmarketing Setting by Dilraj S. Grewal, MD, Charles C. Wykoff, MD PhD, Divya D’Souza, MD, Valentine Jehl, MSc, Iulian Alecu, MD, Glenn J. Jaffe, MD

Get full text

Real-World Safety Outcomes with Brolucizumab in Neovascular Age-Related Macular Degeneration: Findings from the IRIS® Registry by Marco A. Zarbin, Mathew W. MacCumber, Helene Karcher, Eser Adiguzel, Andrew Mayhook, Andrew LaPrise, Ver L. Bilano, Franklin Igwe, Michael S. Ip, Charles C. Wykoff

Get full text

Safety and efficacy of ixoberogene soroparvovec in neovascular age-related macular degeneration in the United States (OPTIC): a prospective, two-year, multicentre phase 1 studyRese... by Arshad M. Khanani, David S. Boyer, Charles C. Wykoff, Carl D. Regillo, Brandon G. Busbee, Dante Pieramici, Carl J. Danzig, Brian C. Joondeph, James C. Major, Jr., Adam Turpcu, Szilárd Kiss

Get full text

Impact of Anti-VEGF Treatment and Patient Characteristics on Vision Outcomes in Neovascular Age-related Macular Degeneration by Charles C. Wykoff, MD, PhD, Vincent Garmo, MHS, David Tabano, PhD, Alicia Menezes, MD, Eunice Kim, RPh, MS, Helene B. Fevrier, MSm, Andrew LaPrise, BS, Theodore Leng, MD, MS

Get full text

The Impact of the COVID-19 Pandemic on Tele-ophthalmology-Based Retinal Screening by Marie L. R. Rasmussen, Lasse J. Cehofski, Julie Davies, Carsten Faber, Mads K. Falk, Jakob Grauslund, Michael S. Hansen, Pearse A. Keane, Sundaram Natarajan, Tunde Peto, Yousif Subhi, Charles C. Wykoff, Danson V. Muttuvelu

Get full text

Safety and Tolerability of Suprachoroidal Axitinib Injectable Suspension, for Neovascular Age-related Macular Degeneration; Phase I/IIa Open-Label, Dose-Escalation Trial by Mark R. Barakat, MD, David Brown, MD, Allen Hu, MD, Rahul N. Khurana, MD, Dennis Marcus, MD, Joel Pearlman, MD, PhD, Charles C. Wykoff, MD, PhD, Barry Kapik, MS, Thomas Ciulla, MD, MBA

Get full text

Magnitude of Visual Acuity Change with ETDRS versus Snellen Testing in Clinical Trials by Mirataollah Salabati, MD, Charles Huang, BS, Alireza Kamalipour, MD, Hannah J. Yu, BS, Raziyeh Mahmoudzadeh, MD, Karen Jeng-Miller, MD, MPH, Eric Chen, MD, Chirag P. Shah, MD, MPH, Charles C. Wykoff, MD, PhD, Jason Hsu, MD

Get full text

Rationale of Basic and Cellular Mechanisms Considered in Updating the Staging System for Diabetic Retinal Disease by M. Elizabeth Hartnett, MD, Ward Fickweiler, MD, PhD, Anthony P. Adamis, MD, Michael Brownlee, MD, Arup Das, MD, PhD, Elia J. Duh, MD, Edward P. Feener, PhD, George King, MD, Renu Kowluru, PhD, Ulrich F.O. Luhmann, PhD, Federica Storti, PhD, Charles C. Wykoff, MD, PhD, Lloyd Paul Aiello, MD, PhD

Get full text

BALATON and COMINO: Phase III Randomized Clinical Trials of Faricimab for Retinal Vein Occlusion by Lars-Olof Hattenbach, MD, PhD, Francis Abreu, PhD, Pablo Arrisi, PhD, Karen Basu, PhD, Carl J. Danzig, MD, Robyn Guymer, MD, PhD, Zdenka Haskova, MD, PhD, Jeffrey S. Heier, MD, Aachal Kotecha, PhD, Ying Liu, PhD, Anat Loewenstein, MD, András Seres, MD, Jeffrey R. Willis, MD, PhD, Charles C. Wykoff, MD, PhD, Liliana P. Paris, MD, PhD

Get full text

SLC16A8 is a causal contributor to age-related macular degeneration risk by Navid Nouri, Bailey Hannon Gussler, Amy Stockwell, Tom Truong, Gyeong Jin Kang, Kristen C. Browder, Yann Malato, Abdoulaye Sene, Sherri Van Everen, Charles C. Wykoff, David Brown, Arthur Fu, James D. Palmer, Jose Ronaldo Lima de Carvalho, Ehsan Ullah, Ranya Al Rawi, Emily Y. Chew, Wadih M. Zein, Bin Guan, Mark I. McCarthy, Jeffrey W. Hofmann, Shawnta Y. Chaney, Heinrich Jasper, Brian L. Yaspan

Get full text